Skip to main content
. 2024 Jan 29;16(3):563. doi: 10.3390/cancers16030563

Table 2.

Mean (±SD) radiomic pre- and post-therapy values in the R-CHOP and R-B group.

Population (n = 80) R-CHOP R-Bendamustine
Primary Endpoint Pre-Therapy Post-Therapy p-Value Pre-Therapy Post-Therapy p-Value
Mean ± SD Apex (HU) −79.12 ± 16.85 −90.33 ± 19.27 <0.001 −78.55 ± 15.09 −83.29 ± 14.66 <0.001
Mean ± SD Anterior Sulcus (HU) −79.12 ± 16.88 −87.16 ± 18.15 <0.001 −76.64 ± 18.24 −81.48 ± 19.05 0.139
Mean ± SD Posterior Sulcus (HU) −79.84 ± 18.54 −94.53 ± 20.23 <0.001 −72.39 ± 15.04 −80.77 ± 20.28 0.018
Mean ± SD Epicardial Fat (HU) −238.08 ± 43.97 −272.02 ± 49.93 <0.001 −227.58 ± 41.17 −245.55 ± 38.52 0.020
Mean ± SD ECV (%) 0.304 ± 0.060 0.432 ± 0.097 <0.001 0.315 ± 0.063 0.361 ± 0.117 0.022
Mean ± SD EF (%) 64.2 ± 3.6 56.4 ± 16.4 0.001 63.4 ± 3.3 61.7 ± 3.8 0.013

SD: standard deviation; HU: Hounsfield units; EF: ejection fraction; ECV: myocardial extracellular volume.